The prognostic role of angiogenesis in breast cancer

Anticancer Research

Volumn 21, Issue 6 B, 2001, Pages 4325-4331

  Leek, Russell D ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Angiogenesis; Breast cancer; Prognosis

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIBODY; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CD34 ANTIGEN;

BREAST CANCER; DENSITY; DRUG TARGETING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; METHODOLOGY; MICROVASCULATURE; MORPHOMETRICS; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; PROGNOSIS; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH; VASCULAR ENDOTHELIUM;

BREAST NEOPLASMS; DISEASE PROGRESSION; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS;

EID: 0035575314     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis
2. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma
3. Cytokine networks in solid human tumors: Regulation of angiogenesis
4. Significance of angiogenesis in cancer therapy
5. Angiogenesis
6. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels
7. Angiogenesis in cancer, vascular, rheumatoid and other disease
8. Vascular endothelial growth-factor is produced by peritoneal-fluid macrophages in endometriosis and is regulated by ovarian-steroids
9. The molecular response of mammalian-cells to hypoxia and the potential for exploitation in cancer-therapy
10. Activation of vascular endothelial growth-factor gene-transcription by hypoxia-inducible factor-1
11. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast
12. The fibroblast growth factor family: Structural and biological properties
13. Macrophage infiltration is associated with VEGF and EGFR expression in breact cancer
14. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
15. Breast carcinoma: Comparative study of tumor vasculature using two endothelial cell markers
16. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
17. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y- antigens - Evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor
18. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis
19. Prognostic and predictive value of intra-tumoral microvessel density in human solid tumours
20. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breactcancer
21. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
22. Microvessel quantitation and prognosis in invasive breast carcinoma
23. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma
24. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer
25. Angiogenesis quantitation as a prognostic factor for primary breast carcinoma 2 cms or less
26. Tumoral vascular density in breast tumors and their effect on recurrence-free survival
27. Pathologic and molecular prognostic factors in breast carcinoma: A 16 year follow up
28. Evaluation of tumour angiogenesis as a prognostic marker in breast cancer
29. Vascular surface area as a prognostic indicator in invasive breast carcinoma
30. Angiogenesis in breast cancer predicts node metastases and survival
31. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen
32. Determination of tumour microvessel density in lymph-node negative breast carcinoma. Does it have a prognostic value?
33. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node- negative breast carcinoma
34. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
35. Microvessel density and vessel invasion in lymph-node-negative breast cancer: Effect on recurrence-free survival
36. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
37. Prognostic value of intratumoral microvessel density, a measure-of tumor angiogenesis, in node-negative breast carcinoma - Results of a multiparametric study
38. The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast cardnomas
39. The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium
40. Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?
41. The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients
42. Assessment of intratumoral vascularization (angiogenesis) in breast cancer prognosis
43. Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: A multiparametric and immunohistochemical analysis
44. Prognostic significance of tumor angiogenesis in advanced breast carcinoma: An Indian experience
45. Angiogenesis in breast cancer is related to age but not to other prognostic parameters
46. Angiogenesis in invasive breast carcinoma: Is it associated with parameters of prognostic significance?
47. Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast
48. Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor, and survival
49. The role of macrophages in tumour angiogenesis
50. Expression of the angiogenic factors vascular endothelial-cell growthfactor, acidic and basic fibroblast growth-factor, tumor-growth factorbeta-1, platelet-derived endothelial-cell growth-factor, placenta growth-factor, and pleiotrophin in human primary breast-cancer and its relation to angiogenesis
51. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine
52. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma
53. Vascular endothelial growth-factor and platelet-derived growthfactor are potential angiogenic and metastatic factors in human breast-cancer
54. Prognostic-significance of vascular endothelial growth-factor protein in node-negative breast-carcinoma
55. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
56. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migraffon
57. Secretion of epidermal growth factor by macrophages associated with breast carcinoma